Extract not available.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MERCK & CO.
Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.
Merck & Co. is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
969 news
and
178 blog
items.
Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from
like-minded professionals.
News
Please add new articles to this topic
demand for treatments. BeiGene Ltd. hired 20 U.S.-educated scientists from companies including Johnson & Johnson...
from Abbott Park, Illinois-based Abbott Laboratories; and Remicade, sold by New Brunswick, New Jersey-based Johnson...
Extract not available.
Executive Vice President, CFO and Treasurer of Inspire Pharmaceuticals from May 2003 through its $430 million...
rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from...
Extract not available.
the U.S. Court of Appeals in Philadelphia to reverse a lower court���s ruling that accords between Merck & Co.
from hepatitis C who either have not been treated or were not cured by other drugs. Incivek and Merck & Co.
great, and Emcor is nonexistent or OK where USM is great." Annual meetings Tuesday: Healthcare Services Group,...
items. Adcock finalised the acquisition Ghana's Ayrton during the period and teamed up with U.S. firm Merck & Co...
Pharmaceuticals won regulatory approval on Monday for a new hepatitis C drug, setting off a marketing battle with Merck...
Stock quotes in this article:MRK At their meeting today, the Board of Directors of Merck (NYSE: MRK), known as MSD...
Ghana's Ayrton last year and increased its pipeline of drugs by teaming up with U.S. firm Merck & Co (MRK.
Extract not available.
rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from...
the most exciting in the industry��� and should help it outpace profit growth at drugmakers including Pfizer Inc.
the most exciting in the industry��� and should help it outpace profit growth at drugmakers including Pfizer Inc.
of treatment for the liver-destroying condition and setting up a head-to-head marketing battle with a rival medicine...
the mid-sized caps, shares of Parexel International (NASDAQ:PRXL) Vertex Pharmaceuticals (NASDAQ:VRTX) Incivek will...
Pharmaceuticals won regulatory approval on Monday for a new hepatitis C drug, setting off a marketing battle with Merck...
after an FDA advisory panel unanimously recommended the drug last month. The agency approved another hepatitis C drug,...
after an FDA advisory panel unanimously recommended the drug last month. The agency approved another hepatitis C drug,...
intravenous therapies. The Cambridge, Mass., company has already started promoting the drug in advance of approval.
More from Adam Feuerstein Biotech Stock Mailbag: Live ChatEuropean Regulators Approve New Drugs Market Activity Vertex...
Top Sources: Merck & Co.
- Reuters
- BusinessWeek
- Philadelphia Inquirer
- MarketWatch
- Wall Street Journal Online
- Financial Times
- businesswire.com
- Forbes.com
- latimes.com
- inpharm.com
account